Has Hunter McLendon received payments from drug or device companies?

Yes. Drug and device makers reported $5,183 in general payments to Hunter McLendon across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hunter McLendon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hunter McLendon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hunter McLendon

Psychiatry · Jackson, MSNPI 1871056275

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 203 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,234, more than ten times the $103 reported in 2019.

$5,183in general payments, 2019–2025

Across 203 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$834
Teva Pharmaceuticals USA, Inc.$798
Johnson & Johnson$687
Neurocrine Biosciences, Inc.$687
Otsuka America Pharmaceutical, Inc.$617
E.r. Squibb & Sons, L.L.C.$585
plus $976 from 7 others

What the payments were for

Food & beverage$5,183100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	21	$834
Teva Pharmaceuticals USA, Inc.	31	$798
Johnson & Johnson	27	$687
Neurocrine Biosciences, Inc.	30	$687
Otsuka America Pharmaceutical, Inc.	20	$617
E.r. Squibb & Sons, L.L.C.	26	$585
Vanda Pharmaceuticals Inc.	12	$269
Lundbeck LLC	16	$239
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$159
AbbVie	6	$153
Indivior Inc.	6	$107
Axsome Therapeutics, Inc.	2	$35
Genentech USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,183 in reported general payments places this provider in the 85th percentile of 219 psychiatry providers in Mississippi.

See all psychiatry providers in Mississippi →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	18	$318
Escitalopram Oxalate	11	$12

Paid to pharmacies, not to this prescriber.

Other psychiatry in Jackson

Jon JacksonJackson$834K
John NortonJackson$173K
Krishan GuptaJackson$26K
Kristen BevillJackson$12K
Mark ResterJackson$9K
Roy ReevesJackson$8K
Andrew BishopJackson$6K
Douglas ByrdJackson$5K
Marshall BelagaJackson$5K
Amandeep SinghJackson$3K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →